The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

New England Journal of Medicine

Volumn 336, Issue 20, 1997, Pages 1401-1408

  Struewing, Jeffery P ^a,b,e   Hartge, Patricia ^a   Wacholder, Sholom ^a   Baker, Sonya M ^b   Berlin, Martha ^c   McAdams, Mary ^d   Timmerman, Michelle M ^b   Brody, Lawrence C ^b   Tucker, Margaret A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^c WESTAT   (United States)

^d IMS   (United States)

^e Division of Cancer Epidemiology and Genetics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; COLON CANCER; CONTROLLED STUDY; FEMALE; GENE MUTATION; HETEROZYGOSITY; HIGH RISK POPULATION; HUMAN; JEW; MAJOR CLINICAL STUDY; MALE; OVARY CANCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSTATE CANCER; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; BRCA2 PROTEIN; BREAST NEOPLASMS; COLONIC NEOPLASMS; FEMALE; GENES, BRCA1; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; INCIDENCE; JEWS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASMS; OVARIAN NEOPLASMS; PROSTATIC NEOPLASMS; RISK; TRANSCRIPTION FACTORS;

EID: 0030910022     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199705153362001     Document Type: Article

References (34)

1. Easton DF, Bishop DT, Ford D, Crockford GP, Breast Cancer Linkage Consortium. Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 1993;52:678-701.
2. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE, Breast Cancer Linkage Consortium. Risks of cancer in BRCAl-mutation carriers. Lancet 1994;343:692-5.
3. Wooster R, Neuhausen SL, Mangion J, et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994;265:2088-90.
4. Easton DF, Ford D, Bishop DT. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 1995;56:265-71.
5. Couch FJ, Weber BL, Breast Cancer Information Core. Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Hum Mutat 1996;8:8-18.
6. Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995;378:789-92.
7. Tavtigian SV, Simard J, Rommens J, et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet 1996;12: 333-7.
8. Struewing JP, Brody LC, Erdos MR, et al. Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer. Am J Hum Genet 1995;57:1-7.
9. Tonin P, Scrova O, Lenoir G, et al. BRCA1 mutations in Ashkenazi Jewish women. Am J Hum Genet 1995;57:189.
10. Neuhausen S, Gilewski T, Norton L, et al. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Nat Genet 1996;13:126-8.
11. FitzGerald MG, MacDonald DJ, Krainer M, et al Germ-line BRCA1 mutations in Jewish and non-Jewish women with early-onset breast cancer N Engl J Med 1996;334:143-9.
12. Couch FJ, Farid LM, DeShano ML, et al. BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat Genet 1996;13: 123-5.
13. Struewing JP, Abeliovich D, Peretz T, et al. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals, Nat Genet 1995;11;198-200.
14. Roa BB, Boyd AA, Volcik K, Richards CS. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 1996;14;185-7.
15. Oddoux C, Struewing JP, Clayton CM, et al. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is ap. proximately 1%. Nat Genet 1996;14:188-90.
16. Sommer SS, Groszbach AR, Bottema CDK. PCR amplification of specific alleles (PASA) is a general method for rapidly detecting known singlebase changes. Biotechniques 1992;12:82-7
17. Offit K, Gilewski T, McGuire P, et al. Germline BRCA1 185delAG mutations in Jewish women with breast cancer. Lancet 1996;347:1643-5.
18. Gayther SA, Warren W, Mazoyer S, et al, Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat Genet 1995;11:428-33.
19. Gayther SA, Mangion J, Russell P, et aK Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat Genet 1997;15:103-5.
20. Tonin P, Ghadirian P, Phelan C, et al. A large multisite cancer family is linked to BRCA2. J Med Genet 1995;32:982-4.
21. Thorlacius S, Olafsdottir G, Tryggvadottir L, et al. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat Genet 1996;13:117-9.
22. Phelan CM, Lancaster JM, Tonin P, et al. Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nat Genet 1996;13: 120-2.
23. Berman DB, Wagner-Costalas J, Schultz DC, Lynch HT, Daly M, Godwin AK. Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: a genetic study of 15 185delAG-mutation kindreds. Am J Hum Genet 1996;58:1166-76.
24. Muto MG, Cramer DW, Tangir J, Berkowitz R, Mok S. Frequency of the BRCA1 185delAG mutation among Jewish women with ovarian cancer and matched population controls. Cancer Res 1996;56:1250-2.
25. Tonin P, Weber B, Offit K, et ai. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med 1996;2:1179-83.
26. Langston AA, Malone KE, Thompson JD, Daling JR, Ostrander EA. BRCA1 mutations in a population-based sample of young women with breast cancer. N Engl J Med 1996;334:137-42.
27. Brinton LA, Daling JK, Liff JM, et al. Oral contraceptives and breast cancer risk among younger women, J Natl Cancer Inst 1995;87:827-35.
28. Hartge P, Schiffman MH, Hoover R, McGowan L, Lesher L, Norris HJ. A case-control study of epithelial ovarian cancer. Am J Obstet Gynecol 1989;161:10-6.
29. Egan KM, Newcomb PA, Longnecker MP, et al. Jewish religion and risk of breast cancer Lancet 1996;347:1645-6.
30. Feuer EJ, Wun LM, Boring CC, Flanders WD, Timmel MJ, Tong T. The lifetime risk of developing breast cancer J Natl Cancer Inst 1993;85: 892-7
31. Lerman C, Croyle R. Psychological issues in genetic testing for breast cancer susceptibility. Arch Intern Med 1994;154:609-16.
32. Rothenberg KH. Genetic information and health insurance: state legislative approaches. J Law Med Ethics 1995;23:312-9.
33. Hubbard R, Lewontin RC. Pitfalls of genetic testing. N Engl J Med 1996;334:1192-4.
34. Lapham EV, Kozma C, Weiss JO. Genetic discrimination; perspectives of consumers. Science 1996;274:621-4.